Genentech

KADCYLA - Cost

Last Updated: April 1st, 2024

HCPCS:

J9354

HCPCS Code Descriptor:

Injection, ado-trastuzumab emtansine, 1 mg

Medicare Payment Limit:

The KADCYLA Medicare Payment Limit is $38.438

Average Sale Price:

KADCYLA ASP cost available once logged in.

Medicare Co-Insurance Percentage:

The KADCYLA Medicare Co-insurance percentage is 20%. KADCYLA's Medicare Co-insurance amount is $7.69 per HCPCS unit.

APC Code:

The Kadcyla APC Code is: 9131

APC Payment Limit:

The APC Payment Limit for KADCYLA is available. Login to view.

Kadcyla Cost Information:

KADCYLA, manufactured by Genentech, is aligned to HCPCS J9354. KADCYLA became effective on January 1, 2014 and has two NDCs mapped to J Code: J9354. Since 2016, prices have increased every six months. During this time, AWP and WAC increased by around 35% while ASP rose slightly over 30%.

ACCESS PRICING AND MORE BY REGISTERING

Kadcyla’s wholesale acquisition cost (WAC) information was last updated on:
January 1, 2024
Kadcyla’s average wholesale price (AWP) information was last updated on:
January 1, 2023

Kadcyla Cost Graph: